9/9/2011
By Duff Wilson - The New York TimesTwo advisory panels to the Food and Drug Administration on Friday recommended increasing the cautionary language on
|
9/9/2011
September 9, 2011 - Public CitizenTestimony to Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Mana
|
7/8/2011
WASHINGTON -(Dow Jones)- A Food and Drug Administration advisory panel will meet in September to discuss the long-term safety of drugs used
|
6/12/2011
By Susan Ince
Osteoporosis medication is supposed to prevent bone breaks. But if it's taken too long, the opposite can happen. What you need about os
|
2/22/2011
ScienceDaily (Feb. 22, 2011) — Older women who used bisphosphonates (medications that prevent loss of bone mass) for five years or more were more
|
12/16/2010
MHRA Warns UK Doctors To Monitor Cancer Patients For ONJ Where There Is Concomitant Use Of These Drugs
(Posted by Tom Lamb at DrugInjury
|
11/10/2010
By NATASHA SINGER - New York TimesPublished: November 10, 2010
Judith Graves, a 67-year-old retired investigator for the United States Army, dev
|
11/10/2010
Safety Announcement[03-10-2010] Patients and healthcare professionals may have questions about oral bisphosphonate medications and atypical subtr
|
10/25/2010
Published By Jennifer P. Schneider, MD, PhD
Several recent medical articles have described multiple cases of unusual low-impact subtrochanteric stres
|
10/25/2010
Doctor leads effort to restrict the use of bone drug Fosamax.
Full Article Here: http://azstarnet.com/news/science/health-med-fit/article
|
10/25/2010
By Dr Jeffrey Dach MD
A recent NEJM article by Dennis Black MD denying a link between Fosamax and spontaneous mid-femur fractures
|
10/16/2010
By Gina KolataThe New York TimesPublished October 16, 2010
n the past month, the Food and Drug Administration has concluded that in some ca
|
10/13/2010
By Duff Wilson via New York Times
Updated: The Food and Drug Administration issued a warning on Wednesday linking long-term use of pop
|
10/13/2010
ROCKVILLE, Md -- October 13, 2010 -- The US Food and Drug Administration (FDA) today warned patients and healthcare providers about the possible risk
|
9/14/2010
By Ed Silverman Six months after the FDA determined there is no link between bisphosphonates and thigh-bone fractures, a task force says otherwis
|
9/14/2010
Published by The American Society For Bone and Mineral Research
Drugs Commonly Prescribed for Osteoporosis Patients are Effective at Reducing Ris
|
6/1/2010
Law360, New York (May 28, 2010) -- Finding that NovartisPharmaceutical Corp. failed to come clean about consumer ads for its controversial A
|
3/19/2010
Originally published on Drugs.com.WEDNESDAY, March 19 -- In the latest research to cast a shadow on the safety of a popular bone-strengtheni
|
3/8/2010
Fosamax, manufactured by Merck, is a bisphosphonate medication prescribed to treat osteoporosis and bone loss. A medical study in the Journal of Ortho
|
10/22/2009
By Tristan Scott - Missoulian.comJurors slapped a Swiss pharmaceutical company with a $3.2 million verdict Wednesday, wrapping up a Missoula woman's l
|
11/3/2008
Are you a victim and don’t even know it yet? Fosamax, Aredia, Zometa and Actonel, medications used to protect weakened bones of osteoporosis, multiple
|
7/15/2008
Report of the Council on Scientific AffairsAmerican Dental Association July, 2008
(PDF) Report located here.
http://www.ada.org/sections/professiona
|
6/5/2008
Originally Published on Newsinferno.com
Fosamax, a popular drug for treating osteoporosis, has been linked to a rare type of femur fracture. Th
|
5/9/2006
With thousands of Vioxx cases already in the courts, the drugmaker faces 15 suits over an osteoporosis drug blamed for rotting the jaw bone.By Aaron S
|
4/13/2006
Theresa Agovino - The Associated Press
Merck & Co., which is already facing a raft of cases over its pain reliever Vioxx, may need to hire additi
|
1/1/2006
After eight operations on patients whose jawbones turned out to be dead, oral surgeon Salvatore Ruggiero began doing some research in February 2001. H
|